As a high-tech company, Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing of POCT products since its establishment in Aug,2002. Sinocare focuses intensively and extensively on the R&D of products and innovation of technology, casting our look into the future, to deliver significant benefits for people pursuing healthy living. In March, 2012, Sinocare Inc. was listed on Shenzhen Stock Exchange, abbreviated as "Sinocare" with stock code 300298. We passed ISO13485 and our products were certified by EU CE. The company's Sinocare glucometer series and its test strips has won an universal recognition from a large number of consumers thanks to its accuracy, simplicity and affordability. The product is not only popular in China, but also exports in large scale. Observing the values of “equality, honesty, innovation and excellence”, Sinocare conducts continuous innovation and establishes "portable laboratory" based on POCT product. The company aims at providing quality product and service for China’s chronic disease management, help chronic disease patients improve living quality and reduce the burden of social medical care system.